Medical nutrition therapy in hospitalized patients with pemphigus vulgaris

Main Article Content

Bintari Anindhita
Nurul Ratna Mutu Manikam


Dysphagia due to involvement of the oral, pharyngolaryngeal, and esophageal mucosa and increased catabolism due to epidermal shedding can contribute to a decline in nutritional status in pemphigus vulgaris (PV) patients. On the other hand, decreased lean body mass is associated with immune system impairment, increased risk of infection, and delayed wound healing in PV patients, therefore, nutritional screening and assessment are necessary. Medical nutritional therapy in PV patients aims to overcome the metabolic response to the insults, prevent further malnutrition, modulate the immune system, and accelerate wound healing process. An aggressive nutritional support to minimize protein loss during the phase of mucocutaneous lesion healing is needed in patients with PV. Aside from macronutrient adequacy, micronutrients including vitamin A supplementation can be considered to accelerate wound healing process. Medical nutritional therapy including provision of adequate macronutrients, micronutrients, addressing dehydration and electrolyte imbalances should be the cornerstone of multidisciplinary treatment in PV patients.


Download data is not yet available.

Article Details

Author Biographies

Bintari Anindhita, Faculty of Medicine Universitas Indonesia – dr. Cipto Mangunkusumo General Hospital. Jakarta, Indonesia

Department of nutrition

Nurul Ratna Mutu Manikam, Faculty of Medicine Universitas Indonesia – dr. Cipto Mangunkusumo General Hospital. Jakarta, Indonesia

Department of Nutrition


1. Kridin K, Schmidt E. Epidemiology of Pemphigus. JID Innov 2021; 1: 100004.
2. Kridin K. Pemphigus Group: Overview, Epidemiology, Mortality, and Comorbidities. Immunol Res 2018; 66: 255–270.
3. Budianti W, Fitri E, Meilinda P, et al. Clinical characteristics and treatment regimen of pemphigus patients: A retrospective study. J Gen Proced Dermatol Venereol Indones 2021; 5: 79–85.
4. Fathallah N, Slim R, Larif S, et al. Drug-Induced Hyperglycaemia and Diabetes. Drug Saf 2015; 38: 1153–68.
5. Poetker DM, Reh DD. A comprehensive review of the adverse effects of systemic corticosteroids. Otolaryngol Clin North Am 2010; 43: 753–768.
6. Peckett AJ, Wright DC, Riddell MC. The effects of glucocorticoids on adipose tissue lipid metabolism. Metabolism: Clinical and Experimental 2011; 60: 1500–1510.
7. Nadelmann E, Czernik A. Wound Care in Immunobullous Disease. In: Muzeyyen Gonul, Seray Cakmak (eds) Autoimmune Bullous Diseases. 2018, pp. 213–40.
8. Diotallevi F, Campanati A, Martina E, et al. The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review. Nutrients 2022; 14: 1–20.
9. Monçale Campos AG. Mucosal Manifestations of Pemphigus Vulgaris: A Key Sign for Early Diagnosis. Global Journal of Otolaryngology 2019; 19: 1–4.
10. Barchitta M, Maugeri A, Favara G, et al. Nutrition and Wound Healing : An Overview Focusing on the Beneficial Effects of Curcumin. Int J Mol Sci 2019; 20: 1–14.
11. Stoj V, Lu J. Nutrition and bullous diseases. Clin Dermatol 2022; 40: 156–165.
12. Fang H, Li Q, Wang G. The role of T cells in pemphigus vulgaris and bullous pemphigoid. Autoimmun Rev 2020; 19: 102661.
13. Popescu I, Statescu L, Vata D, et al. Pemphigus vulgaris - approach and management (Review). Exp Ther Med 2019; 5056–5060.
14. Stoj V, Lu J. Nutrition and bullous diseases. Clin Dermatol 2022; 156–165.
15. Payne AS, Stanley JR. Pemphigus. In: Kang S, Amagai M, Bruckner AL, et al. (eds) Fitzpatrick’s Dermatology. 2019, p. 909.
16. Grada A, Obagi Z, Phillips T. Management of chronic wounds in patients with pemphigus. Chronic Wound Care Management and Research 2019; 6: 89–98.
17. Kneisel A, Hertl M. Autoimmune bullous skin diseases . Part 1 : Clinical manifestations. JDDG 2011; 2011: 844–857.
18. Ruocco E, Baroni A, Wolf R, et al. Life-threatening bullous dermatoses : Pemphigus vulgaris. Clin Dermatol 2005; 23: 223–226.
19. Joly P, Horvath B, Patsatsi, et al. Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV). Journal of the European Academy of Dermatology and Venereology 2020; 34: 1900–1913.
20. Kasperkiewicz M, Ellebrecht CT, Takahashi H, et al. Pemphigus. Nature Reviews Disease Primers 2017; 3: 1–16.
21. Kridin K, Zelber-Sagi S, Bergman R. Risk factors for lethal outcome in patients with pemphigus: a retrospective cohort study. Eur J Dermatol 2018; 28: 26–37.
22. Rzany B, Partscht K, Jung M, et al. Risk Factors for Lethal Outcome in Patients With Bullous Pemphigoid. Arch Dermatol 2002; 138: 903–8.
23. Berger MM, Shenkin A, Amrein K, et al. ESPEN micronutrient guideline. Clinical Nutrition.
24. Vinall C, Stevens L, Mcardle P. Pemphigus vulgaris: a multidisciplinary approach to management. BMJ Case Rep 2013; 1–4.
25. Moravvej H, Mozafari N, Younespour S. Serum 25-hydroxy vitamin D level in patients with pemphigus and its association with disease severity. Clinical Dermatology 2016; 41: 142–147.
26. Whittier X, Saag KG. Glucocorticoid-induced Osteoporosis. Rheumatic Disease Clinics of North America 2016; 42: 177–189.
27. Meier R, Berner Y, Sobotka L. Nutritional Screening and Assessment. ESPEN Life Long Learning Programme 2017; 3: 1–23.
28. Cederholm T, Jensen GL, Correia MITD, et al. GLIM criteria for the diagnosis of malnutrition – A consensus report from the global clinical nutrition community. J Cachexia Sarcopenia Muscle 2019; 10: 207–217.
29. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 2019; 48: 16–31.
30. Hussain MH, Tanweer F, Sakagiannis G, et al. Pemphigus Vulgaris and Bullous Pemphigoid of the Upper Aerodigestive Tract: A Review Article and Novel Approaches to Management. ORL 2021; 83: 395–403.
31. Gomes F, Schuetz P, Bounoure L, et al. ESPEN guidelines on nutritional support for polymorbid internal medicine patients. Clinical Nutrition 2018; 37: 336–353.
32. American Diabetes Association. Introduction : Standards of Medical Care in Diabetes — 2022. Diabetes Care 2022; 45: 2021–2022.
33. Sawada Y, Saito-Sasaki N, Nakamura M. Omega 3 Fatty Acid and Skin Diseases. Front Immunol 2021; 11: 1–8.
34. Stechmiller JK. Understanding the Role of Nutrition and Wound Healing. Nutr Clin Pract 2010; 25: 61–68.
35. Buckley L, Guyatt G, Fink HA, et al. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Care Res (Hoboken).
36. Holick MF, Binkley NC, Bischoff-ferrari HA, et al. Evaluation , Treatment , and Prevention of Vitamin D Deficiency : an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011; 25: 1911–1930.
37. Fletcher J, Bishop EL, Harrison SR, et al. Autoimmune disease and interconnections with vitamin D. Endocrine Connections; 11.
38. Souberbielle JC, Body JJ, Lappe JM, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmunity Reviews 2010; 9: 709–715.
39. Zinder R, Cooley R, Vlad LG, et al. Vitamin A and Wound Healing. Nutrition in Clinical Practice 2019; 34: 839–849.
40. Huang Z, Liu Y, Qi G, et al. Role of Vitamin A in the Immun
41. Tavakolpour S, Daneshpazhooh M, Reza H, et al. International Immunopharmacology The dual nature of retinoic acid in pemphigus and its therapeutic potential : Special focus on all-trans Retinoic Acid. Int Immunopharmacol 2016; 36: 180–186.
42. Gropper SS, Smith JL, Carr TP. Advanced Nutrition and Human Metabolism. 7th ed. Cengage Learning, 2018.
43. Polcz ME, Barbul A. The Role of Vitamin A in Wound Healing. Nutrition in Clinical Practice 2019; 34: 695–700.